Look at these pore souls. Dr. Scott Walter — a board-certified dermatologist in the Denver area — is raising awareness about ...

Rosacea is thought to affect around 5% of the global population. Credit: Alona Siniehina / Shutterstock. The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand ...

An eye doctor has opened up on finding parasitic eye infections in his patients that he says are commonly caused by one ...

Demodex is a specific genus of microscopic ... the immune system and have therefore been linked with rosacea. Some rosacea treatments such as Soolantra, which contains topical ivermectin, can ...

Rosacea patient before and after 2 laser treatments: After treatment (right), the many tiny blood vessels on this patient’s cheek cleared. If you have rosacea, laser or light therapy may be a part of ...

Rosacea is a common skin condition, which can also affect your eyes. Rosacea in his eyes and on his skin: Treatment can alleviate the rosacea on this man’s skin and in his eyes. When rosacea develops ...

(RTTNews) - Journey Medical (DERM) announced the FDA has approved Emrosi for the treatment of inflammatory lesions of rosacea in adults. Emrosi was developed in collaboration with Dr. Reddy's ...

The Food and Drug Administration has approved Emrosi ™ (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions (papules and pustules) of rosacea in adults.